EBITDA at other companies
Other financials
Where this comes from
Calculated from Ironwood Pharmaceuticals’s reported figures.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's EBITDA?
- Ironwood Pharmaceuticals (IRWD) reported EBITDA of $73.02M in Q1 2026.
- How has Ironwood Pharmaceuticals's EBITDA changed year-over-year?
- Ironwood Pharmaceuticals's EBITDA increased by 355.0% year-over-year, from -$28.63M to $73.02M.
- What is the long-term trend for Ironwood Pharmaceuticals's EBITDA?
- Over 4 years (2021 to 2025), Ironwood Pharmaceuticals's EBITDA has grown at a -19.0% compound annual growth rate (CAGR), from $233.76M to $100.38M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.